STAT3 and Sepsis: Our studies demonstrate that inhibiting the STAT3 pathway can downregulate pro-inflammatory cytokines, reduce tissue inflammation, minimize the development of key organ failure, and improve survival in septic mice, suggesting that STAT3 may be developed as an attractive and potential therapeutic target for treatment of sepsis.